BioNTech vaccine reduces severity of symptoms and delays progression, study suggests
(Newser) -
BioNTech has a second vaccine making headlines, but this one has nothing to do with COVID. Instead, it shows promise against multiple sclerosis. In a study at Science , researchers say the vaccine reduced the severity of symptoms in lab mice, delayed the disease's progression in mice with early signs...